Mobile

Receptorial radiotherapy with 177Lu DOTATATE in somatostatine receptors positive tumours, a phase II study. Radioterapia recettoriale con 177Lu-DOTATATE in tumori con recettori positivi per la s...

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-002891-18

Receptorial radiotherapy with 177Lu DOTATATE in somatostatine receptors positive tumours, a phase II study. Radioterapia recettoriale con 177Lu-DOTATATE in tumori con recettori positivi per la somatostatina, studio di fase II

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

disease control rate, DCR, defined as the complete response rate plus the partial response rate plus the rate of patients with stable disease for at least 12 months from therapy start controllo della malattia (risposte complete, parziali e stabilità da almeno 12 mesi)

Critère d'inclusion

  • cancer patients,pazienti oncologici

Liens